• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION ENDOTAK ENDURANCE EZ; IMPLANTABLE LEAD

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION ENDOTAK ENDURANCE EZ; IMPLANTABLE LEAD Back to Search Results
Model Number 0155
Device Problems Defective Device (2588); No Apparent Adverse Event (3189)
Patient Problems Syncope (1610); Bone Fracture(s) (1870); Unspecified Infection (1930); Injury (2348); No Code Available (3191); Syncope/Fainting (4411); Insufficient Information (4580)
Event Date 08/01/2020
Event Type  Injury  
Manufacturer Narrative
(b)(4).
 
Event Description
It was reported that the patient contacted technical services (ts) stating there had been an issue with one of his leads causing him to experience syncope and break 13 to 14 bones.This also led to him being hospitalized for four months.The patient noted that on the way to the hospital four months earlier the lead shorted and caused his chest to feel like it was on fire he also stated he had an infection and the cardiac resynchronization therapy defibrillator (crt-d), left ventricular (lv) lead, right ventricular (rv) and another manufacturer's right atrial (ra) leads were explanted approximately one week ago.The local area sales representative was contacted for additional information.The field representative stated that no further information is available from the clinic beyond another manufacturer's device and leads were implanted.No additional adverse patient effects were reported.
 
Manufacturer Narrative
Patient code 3191 captures the reportable event of surgery.Upon receipt at our post market quality assurance laboratory it was noted that the lead was returned in two segments, severed at approximately 177 mm from the terminal end.Analysis was unable to confirm the infection with laboratory testing.It appeared that some of the segments may not have been returned.Visual inspection revealed stretched and deformed coils in multiple places.The proximal cable coil crimp had been pulled proximally and the shocking coil was stretched.Testing was completed to assess the returned portion of the lead's electrical performance.Measurements were within normal limits.Further visual inspection revealed calcification on both of the lead's shocking coils in a couple places.Insulation abrasion at approximately 100 to 100 mm from the tip of the lead that exposed the rate sense negative lumen was also observed.The polytetrafluoroethylene (ptfe) insulation on the rate sense negative lumen appeared to be intact, however only one side was visible.In this case, we believe the stress was the result of lead contact with another lead.It was noted that this portion of the lead would have been located within the patient's heart.
 
Event Description
It was reported that the patient contacted technical services (ts) stating there had been an issue with one of his leads causing him to experience syncope and break 13 to 14 bones.This also led to him being hospitalized for four months.The patient noted that on the way to the hospital four months earlier the the lead shorted and caused his chest to feel like it was on fire he also stated he had an infection and the cardiac resynchronization therapy defibrillator (crt-d), left ventricular (lv) lead, right ventricular (rv) and another manufacturer's right atrial (ra) leads were explanted approximately one week ago.The local area sales representative was contacted for additional information.The field representative stated that no further information is available from the clinic beyond another manufacturer's device and leads were implanted.No additional adverse patient effects were reported.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ENDOTAK ENDURANCE EZ
Type of Device
IMPLANTABLE LEAD
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
4100 hamline avenue north
saint paul MN 55112
MDR Report Key11182259
MDR Text Key227201340
Report Number2124215-2021-00623
Device Sequence Number1
Product Code LWS
Combination Product (y/n)N
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type consumer
Type of Report Initial,Followup
Report Date 04/06/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received01/15/2021
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Lay User/Patient
Device Expiration Date12/14/2003
Device Model Number0155
Device Catalogue Number0155
Device Lot Number350200
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer12/01/2020
Date Manufacturer Received02/23/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Life Threatening; Other; Required Intervention;
Patient Age66 YR
-
-